PCF Group Spólka Akcyjna Valuation
Is PCF undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PCF when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PCF (PLN18.84) is trading below our estimate of fair value (PLN23.96)
Significantly Below Fair Value: PCF is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PCF?
Other financial metrics that can be useful for relative valuation.
| What is PCF's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | zł677.11m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.4x |
| Enterprise Value/EBITDA | 106.6x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does PCF's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 4.2x | ||
TEN Ten Square Games | 1.1x | -2.3% | zł519.7m |
BLO Bloober Team | 4x | n/a | zł428.1m |
CRJ Creepy Jar | 10.4x | 19.3% | zł341.3m |
HUG Huuuge | 1.2x | -4.5% | zł1.3b |
PCF PCF Group Spólka Akcyjna | 3.9x | 18.4% | zł677.1m |
Price-To-Sales vs Peers: PCF is good value based on its Price-To-Sales Ratio (3.9x) compared to the peer average (4.2x).
Price to Earnings Ratio vs Industry
How does PCF's PE Ratio compare vs other companies in the PL Entertainment Industry?
Price-To-Sales vs Industry: PCF is expensive based on its Price-To-Sales Ratio (3.9x) compared to the Polish Entertainment industry average (3.3x).
Price to Sales Ratio vs Fair Ratio
What is PCF's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 3.9x |
| Fair PS Ratio | 2.8x |
Price-To-Sales vs Fair Ratio: PCF is expensive based on its Price-To-Sales Ratio (3.9x) compared to the estimated Fair Price-To-Sales Ratio (2.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | zł18.84 | zł32.08 +70.2% | 52.1% | zł52.90 | zł15.00 | n/a | 4 |
| Jun ’25 | zł18.50 | zł32.08 +73.4% | 52.1% | zł52.90 | zł15.00 | n/a | 4 |
| May ’25 | zł18.46 | zł39.88 +116.0% | 23.0% | zł52.90 | zł31.00 | n/a | 4 |
| Apr ’25 | zł22.10 | zł42.83 +93.8% | 20.5% | zł52.90 | zł31.50 | n/a | 3 |
| Mar ’25 | zł24.30 | zł42.83 +76.3% | 20.5% | zł52.90 | zł31.50 | n/a | 3 |
| Feb ’25 | zł27.50 | zł42.83 +55.8% | 20.5% | zł52.90 | zł31.50 | n/a | 3 |
| Jan ’25 | zł29.45 | zł42.20 +43.3% | 25.4% | zł52.90 | zł31.50 | n/a | 2 |
| Dec ’24 | zł30.00 | zł40.13 +33.7% | 22.3% | zł52.90 | zł31.50 | n/a | 4 |
| Nov ’24 | zł38.40 | zł43.00 +12.0% | 19.9% | zł52.90 | zł32.00 | n/a | 3 |
| Oct ’24 | zł37.90 | zł42.63 +12.5% | 20.0% | zł52.90 | zł32.00 | n/a | 3 |
| Sep ’24 | zł42.00 | zł42.63 +1.5% | 20.0% | zł52.90 | zł32.00 | n/a | 3 |
| Aug ’24 | zł42.15 | zł42.63 +1.1% | 20.0% | zł52.90 | zł32.00 | n/a | 3 |
| Jul ’24 | zł49.50 | zł43.00 -13.1% | 19.9% | zł52.90 | zł32.00 | zł18.84 | 3 |
| Jun ’24 | zł39.80 | zł43.00 +8.0% | 19.9% | zł52.90 | zł32.00 | zł18.50 | 3 |
| May ’24 | zł38.70 | zł43.00 +11.1% | 19.9% | zł52.90 | zł32.00 | zł18.46 | 3 |
| Apr ’24 | zł40.10 | zł43.00 +7.2% | 19.9% | zł52.90 | zł32.00 | zł22.10 | 3 |
| Mar ’24 | zł37.20 | zł46.97 +26.3% | 28.8% | zł64.80 | zł32.00 | zł24.30 | 3 |
| Feb ’24 | zł37.90 | zł46.97 +23.9% | 28.8% | zł64.80 | zł32.00 | zł27.50 | 3 |
| Jan ’24 | zł39.20 | zł46.30 +18.1% | 30.9% | zł64.80 | zł30.00 | zł29.45 | 3 |
| Dec ’23 | zł41.40 | zł49.60 +19.8% | 29.3% | zł64.80 | zł30.00 | zł30.00 | 3 |
| Nov ’23 | zł47.50 | zł49.60 +4.4% | 29.3% | zł64.80 | zł30.00 | zł38.40 | 3 |
| Oct ’23 | zł41.20 | zł49.60 +20.4% | 29.3% | zł64.80 | zł30.00 | zł37.90 | 3 |
| Sep ’23 | zł47.45 | zł59.40 +25.2% | 9.1% | zł64.80 | zł54.00 | zł42.00 | 2 |
| Aug ’23 | zł50.50 | zł59.40 +17.6% | 9.1% | zł64.80 | zł54.00 | zł42.15 | 2 |
| Jul ’23 | zł53.40 | zł62.47 +17.0% | 9.9% | zł68.60 | zł54.00 | zł49.50 | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.